Article info
PDFPaper
Amantadine for treatment of fatigue in Guillain-Barré syndrome: a randomised, double blind, placebo controlled, crossover trial
- Correspondence to: Dr M P J Garssen Department of Neurology, Erasmus Medical Center Rotterdam, PO Box 1738, 3000 DR Rotterdam, the Netherlands; m.garssen{at}erasmusmc.nl
Citation
Amantadine for treatment of fatigue in Guillain-Barré syndrome: a randomised, double blind, placebo controlled, crossover trial
Publication history
- Received May 24, 2004
- Accepted July 4, 2005
- Revised June 7, 2005
- First published December 16, 2005.
Online issue publication
April 13, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 Journal of Neurology Neurosurgery and Psychiatry